Author:
Ecclestone Hazel,Hamid Rizwan
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Biochemistry
Reference20 articles.
1. •• M. Babjuk, A. Böhle, M. Burger, E. Compérat, E. Kaasinen, J. Palou, M. Rouprêt, B.W.G. van Rhijn, S.F. Shariat, R. Sylvester, R. Zigeuner. EAU guidelines on non-muscle invasive bladder cancer 2016. Available from
https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/#note_203
European guidelines about the use and efficacy of intravesical BCG as well as guidelines about how to manage BCG toxicity.
2. Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002;168(5):1964–70.
3. Morales A, Eidinger D, Bruce AW. Intra-cavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumours. J Urol. 1976;116:180–3.
4. Sylvester RJ. Bacillus Calmette–Guérin treatment of non-muscle invasive bladder cancer. Int J Urol. 2011;18(2):113–20.
5. Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol. 2006;175:2004–10.